A State-of-the-Science Conference for Frontline Health Professionals, Sponsored by Collaborating Federal Health Agencies

CME/CE Information

AMERICAN CONFERNCE FOR THE TREATMENT OF HIV
May 20-23, 2010
Hyatt Regency, Denver, Colorado

Please note that all attendees are required to review all CME/CE information provided, as well as the session agenda prior to registering for the conference.

ABOUT THE CONFERENCE

2010 marks the 4th annual Conference for the Treatment of HIV (ACTHIV), and while young, the now annual conference is well respected within the healthcare community. ACTHIV is designed to provide frontline professionals with up to date information, and research and development within the science that can then translate into the clinical practice of HIV/AIDS prevention and management.

TARGET AUDIENCE

ACTHIV is targeted toward frontline providers of persons at risk of or with HIV infection: physicians (both specialists and primary care/family medicine), nurses, pharmacists, and medical case managers (including social workers). Psychologists, mental health and substance abuse workers, treatment advocates, treatment educators, and other healthcare professionals involved in caring for those infected with HIV may also participate.

GLOBAL CONFERENCE OBJECTIVES

At the conclusion of the conference, participants will be able to:

Design treatment regimens for both treatment-naïve and -experienced patients based on recent changes to the antiretroviral guidelines.
Implement strategies to promote adherence and retention in care
Utilize antiretrovirals for pre- and post-HIV-exposure prophylaxis based on best practices
Assess the role of immune activation on the complications related to HIV disease
Implement clinical monitoring to screen and manage common co-morbidities in people living with HIV/AIDS
Employ evidence-based strategies for diagnosing and managing patients with HIV and cancer.
Diagnose and manage patients with concurrent HIV and mental illness or addiction with special attention to managing drug interactions with psychotropic agents and the timing of psychiatric referral
Adopt and implement prevention strategies for special populations, including youth, men who have sex with men, transgenders, immigrants and those who are incarcerated or homeless, given the unique risks of these populations.
Modify evaluation and treatment approaches to ensure culturally competent delivery of HIV-related health services to special populations, including youth, men who have sex with men, transgenders, immigrants and those who are incarcerated or homeless, based on the needs of these populations.

The following additional global objectives were identified for the HIV Basics session, which is targeted to those providers who are relatively new to HIV care as well as those who have not provided care to persons with HIV infection in some time.

Appropriately test and diagnose HIV infection
Properly assess the immune status of HIV-infected persons entering care
Initiate effective highly active antiretroviral therapy HIV-infected persons.

ACCREDITATION

Physicians:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME (Academy) and ACTHIV. The Academy is accredited by the ACCME to provide continuing medical education for physicians.

The Academy designates this educational activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been reviewed and is acceptable for up to 15.50 Prescribed credits by the American Academy of Family Physicians.

Nurses:

American Academy of CME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Academy designates this educational activity for 15.5 contact hours. In order to receive your CE certificate, you must register for the conference, document attendance, and complete and return an evaluation form.

Pharmacists:

The American Academy of CME, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program provides 15.5 contact hours (1.55 CEUs) of continuing education credit. ACPE Universal Program Number [0297-9999-10-001-L02-P]. In order to obtain your statement of credit, you must register for the conference, document attendance, and complete and return an evaluation form. A statement of credit will be mailed 6-8 weeks following the conference.

Social Workers:

This program is approved by the National Association of Social Workers (Provider # 886476750) for 15.5 Continuing Education Contact Hours (with 2.5 of the 15.5 hours in the Substance Use Disorder Category).

FEES

Registration for the conference is $300 which includes continuing education credits. If you do not wish to apply for credits, you will be deducted $50 when you submit your registration.

Per regulatory guidelines, the educational grants used to support this activity may only be used for healthcare professionals attending the conference. Our grant funding does not allow for participation by non–healthcare providers and/or guests.

DISCLOSURE DECLARATION

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures will be made known to the participants prior to the activity.

SUPPORT

The American Conference for the Treatment of HIV (ACTHIV) is supported by funding from the Office of AIDS Research of the National Institutes of Health. The educational portion of ACTHIV is supported by educational grants from Bristol-Myers Squibb and Gilead Sciences. Please check back for updates as additional supporters are confirmed.

ADA

In compliance with the Americans with Disabilities Act of 1990, ACTHIV will make all reasonable efforts to accommodate persons with disabilities. Please contact our headquarters at 202-973-8658 with your request.